Characterization of proteins Msp22 and Msp75 as vaccine antigens of Moraxella catarrhalis

Abstract Moraxella catarrhalis is a respiratory tract pathogen causing otitis media in children and respiratory tract infections in adults with chronic obstructive pulmonary disease. This study examined two newly identified proteins as potential vaccine antigens. Antisera raised to recombinant purif...

Full description

Saved in:
Bibliographic Details
Published inVaccine Vol. 27; no. 50; pp. 7065 - 7072
Main Authors Ruckdeschel, Elizabeth A, Brauer, Aimee L, Johnson, Antoinette, Murphy, Timothy F
Format Journal Article
LanguageEnglish
Published Kidlington Elsevier Ltd 23.11.2009
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Abstract Moraxella catarrhalis is a respiratory tract pathogen causing otitis media in children and respiratory tract infections in adults with chronic obstructive pulmonary disease. This study examined two newly identified proteins as potential vaccine antigens. Antisera raised to recombinant purified proteins Msp22 and Msp75 recognized corresponding native proteins in multiple strains of M. catarrhalis . Vaccine formulations individually administered subcutaneously and intranasally showed enhanced clearance of M. catarrhalis in a mouse pulmonary clearance model by both routes of administration. Msp22 and Msp75 are antigenically conserved proteins that induce potentially protective immune responses and should be examined further as vaccine antigens for M. catarrhalis.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
ISSN:0264-410X
1873-2518
DOI:10.1016/j.vaccine.2009.09.062